HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ITGR

Integer Holdings Corporation

Healthcare — Medical Devices

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Buy 1.9 / 5 10 analysts
$126.43
+$0.08 (+0.06%)
Target: $101.20 (-20.0%)

Price History

52-Week Range
Sign in to add ITGR to a watchlist or set price alerts.

Fundamentals

Market Cap$4.12B
P/E Ratio (TTM)24.99
Forward P/E17.78
EPS (TTM)$4.85
Dividend Yield-
Profit Margin7.64%
Revenue Growth0.50%
ROE8.58%
Debt/Equity81.41
Recommendation Buy 1.9
Analyst Target$101.20
Analysts10
Next Earnings Aug 3, 2026 BMO
Indexes -

Technical Indicators

RSI (14)80.7
Beta0.64
SMA 20$97.46
SMA 40$94.73
52-Week High$123.50
52-Week Low$62.00
50-Day Avg$93.80
200-Day Avg$85.02
Avg Volume531.5K
Volume$2.36M

Performance Analysis

NEUTRAL

ITGR presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($123.50), which may indicate limited upside.
- RSI at 80.7 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 0.5% year-over-year.
+ Wall Street consensus is "Buy" from 10 analysts.
- Average analyst target of $101.20 implies 20.0% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:16 UTC

Back to Screener Export Report